Nicotinic Agonists and Psychosis

Publisher： Bentham Science Publishers

E-ISSN： 2212-5299|1|2|149-162

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.1, Iss.2, 2002-04, pp. : 149-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuronal nicotinic acetylcholine receptor agonists

By Toma Lucio   Barlocco Daniela   Gelain Arianna  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 7, 2004-07 ,pp. : 1029-1040

Informa Healthcare

Access to resources Recommend Favorite

Partial Dopamine Agonists and the Treatment of Psychosis

By  

Current Neuropharmacology, Vol. 3, Iss. 1, 2005-01 ,pp. : 3-8

Bentham Science Publishers

Access to resources Recommend Favorite

HM74a Agonists: Will they be the New Generation of Nicotinic Acid?

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 5, 2009-04 ,pp. : 428-435

Bentham Science Publishers

Access to resources Recommend Favorite

Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 2, 2002-04 ,pp. : 141-147

Bentham Science Publishers

Access to resources Recommend Favorite

The potential of neuronal nicotinic acetylcholine receptor agonists for treating CNS conditions

By Decker Michael W   Gopalakrishnan Murali   Meyer Michael D  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 9, 2008-09 ,pp. : 1027-1040

Informa Healthcare

Access to resources Recommend Favorite